$STHO
Star Holdings

2024 Q2 Form 10-Q Financial Statement

#000195336624000014 Filed on May 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $30.55M $25.44M $16.79M
YoY Change 19.9% 51.49%
Cost Of Revenue $31.09M $24.02M $19.47M
YoY Change 26.11% 23.38%
Gross Profit -$534.0K $1.414M -$2.680M
YoY Change -164.34% -152.76%
Gross Profit Margin -1.75% 5.56% -15.96%
Selling, General & Admin $4.686M $7.493M $14.20M
YoY Change -38.75% -47.23%
% of Gross Profit 529.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.178M $1.183M -$1.330M
YoY Change 8.07% -188.95%
% of Gross Profit 83.66%
Operating Expenses $5.870M $8.749M $17.27M
YoY Change -34.71% -49.34%
Operating Profit -$6.404M -$7.335M -$19.95M
YoY Change -21.52% -63.23%
Interest Expense -$21.55M -$41.66M -$70.79M
YoY Change -73.31% -41.15%
% of Operating Profit
Other Income/Expense, Net $8.000K $56.00K $288.0K
YoY Change -97.46% -80.56%
Pretax Income -$27.95M -$48.99M -$90.74M
YoY Change -68.92% -46.01%
Income Tax $0.00 $2.000K
% Of Pretax Income
Net Earnings -$27.12M -$48.98M -$90.72M
YoY Change -69.86% -46.01%
Net Earnings / Revenue -88.75% -192.57% -540.32%
Basic Earnings Per Share -$2.04 -$3.68 -$6.81
Diluted Earnings Per Share -$2.04 -$3.68 -$6.81
COMMON SHARES
Basic Shares Outstanding 13.32M 13.32M 13.32M
Diluted Shares Outstanding 13.32M 13.32M 13.32M

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $48.28M $45.73M $70.20M
YoY Change -12.06% -34.86%
Cash & Equivalents $48.28M $45.73M $70.20M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $1.746M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $50.02M $45.73M $70.20M
YoY Change -8.88% -34.86%
LONG-TERM ASSETS
Property, Plant & Equipment $236.0M $253.6M $302.0M
YoY Change -19.66% -16.04%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $260.9M $278.6M $397.9M
YoY Change -18.79% -29.99%
Other Assets $9.310M $10.39M $8.500M
YoY Change 221.03% 22.22%
Total Long-Term Assets $551.0M $577.2M $742.9M
YoY Change -14.9% -22.31%
TOTAL ASSETS
Total Short-Term Assets $50.02M $45.73M $70.20M
Total Long-Term Assets $551.0M $577.2M $742.9M
Total Assets $601.0M $622.9M $813.1M
YoY Change -14.43% -23.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.0K
YoY Change
Accrued Expenses $12.62M $7.419M $6.000M
YoY Change 75.29% 23.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.62M $7.419M $6.100M
YoY Change 75.29% 21.62%
LONG-TERM LIABILITIES
Long-Term Debt $197.2M $195.0M $251.8M
YoY Change -13.28% -22.55%
Other Long-Term Liabilities $34.46M $35.75M $31.40M
YoY Change -7.13% 13.87%
Total Long-Term Liabilities $231.7M $230.8M $283.2M
YoY Change -12.41% -18.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.62M $7.419M $6.100M
Total Long-Term Liabilities $231.7M $230.8M $283.2M
Total Liabilities $244.3M $238.2M $296.3M
YoY Change -10.09% -19.61%
SHAREHOLDERS EQUITY
Retained Earnings -$272.5M -$245.4M
YoY Change 50.77%
Common Stock $13.00K $13.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $335.3M $362.4M $516.8M
YoY Change
Total Liabilities & Shareholders Equity $601.0M $622.9M $813.1M
YoY Change -14.43% -23.39%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$27.12M -$48.98M -$90.72M
YoY Change -69.86% -46.01%
Depreciation, Depletion And Amortization $1.178M $1.183M -$1.330M
YoY Change 8.07% -188.95%
Cash From Operating Activities -$6.407M -$14.23M $18.67M
YoY Change 55.89% -176.22%
INVESTING ACTIVITIES
Capital Expenditures $375.0K $6.205M -$8.220M
YoY Change -92.82% -175.49%
Acquisitions
YoY Change
Other Investing Activities $8.251M -$30.00K $49.22M
YoY Change -52.36% -100.06%
Cash From Investing Activities $7.876M $9.634M $57.45M
YoY Change -34.91% -83.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.35M
YoY Change
NET CHANGE
Cash From Operating Activities -6.407M -14.23M 18.67M
Cash From Investing Activities 7.876M 9.634M 57.45M
Cash From Financing Activities -10.35M
Net Change In Cash 1.469M -4.596M 65.77M
YoY Change -108.33% -106.99%
FREE CASH FLOW
Cash From Operating Activities -$6.407M -$14.23M $18.67M
Capital Expenditures $375.0K $6.205M -$8.220M
Free Cash Flow -$6.782M -$20.44M $26.89M
YoY Change -27.31% -175.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
97481000
CY2024Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
22972000
CY2023Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
22075000
CY2024Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
74750000
CY2023Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
75406000
CY2024Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
177556000
CY2023Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
181394000
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#DeferredCostsAndOtherAssets
CY2023Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001953366
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Security12b Title
Security12bTitle
Common Shares of Beneficial Interest, $0.001 par value
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13320000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13320000
CY2024Q1 us-gaap Debt Securities Available For Sale Type Extensible List
DebtSecuritiesAvailableForSaleTypeExtensibleList
http://fasb.org/us-gaap/2023#MunicipalNotesMember
CY2023Q4 us-gaap Debt Securities Available For Sale Type Extensible List
DebtSecuritiesAvailableForSaleTypeExtensibleList
http://fasb.org/us-gaap/2023#MunicipalNotesMember
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#DeferredCostsAndOtherAssets
CY2024Q1 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-41572
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Star Holdings
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-6762818
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1114 Avenue of the Americas, 39th Floor
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10036
CY2024Q1 dei City Area Code
CityAreaCode
212
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
930-9400
CY2024Q1 dei Trading Symbol
TradingSymbol
STHO
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13319552
CY2024Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
97722000
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
514000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1080000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
497000
CY2024Q1 stho Notes Receivable And Other Lending Investments Net Of Allowance For Credit Losses
NotesReceivableAndOtherLendingInvestmentsNetOfAllowanceForCreditLosses
22241000
CY2023Q4 stho Notes Receivable And Other Lending Investments Net Of Allowance For Credit Losses
NotesReceivableAndOtherLendingInvestmentsNetOfAllowanceForCreditLosses
20898000
CY2024Q1 us-gaap Other Investments
OtherInvestments
278567000
CY2023Q4 us-gaap Other Investments
OtherInvestments
316451000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45729000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50663000
CY2024Q1 stho Accrued Interest And Operating Lease Income Receivable Net
AccruedInterestAndOperatingLeaseIncomeReceivableNet
613000
CY2023Q4 stho Accrued Interest And Operating Lease Income Receivable Net
AccruedInterestAndOperatingLeaseIncomeReceivableNet
929000
CY2024Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
976000
CY2023Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
997000
CY2024Q1 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
22473000
CY2023Q4 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
22459000
CY2024Q1 us-gaap Assets
Assets
622905000
CY2023Q4 us-gaap Assets
Assets
669197000
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
43173000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
42462000
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
195024000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
192895000
CY2024Q1 us-gaap Liabilities
Liabilities
238197000
CY2023Q4 us-gaap Liabilities
Liabilities
235357000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13320000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13320000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
13000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
13000
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
607623000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
607623000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-245422000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-196441000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
206000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
359000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
362420000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
411554000
CY2024Q1 us-gaap Minority Interest
MinorityInterest
22288000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
22286000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
384708000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
433840000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
622905000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
669197000
CY2024Q1 us-gaap Management Fee Payable
ManagementFeePayable
7600000
CY2023Q4 us-gaap Management Fee Payable
ManagementFeePayable
7200000
CY2024Q1 us-gaap Revenues
Revenues
25436000
CY2023Q1 us-gaap Revenues
Revenues
16786000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1183000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7393000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14098000
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
17000
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1701000
CY2024Q1 us-gaap Other Expenses
OtherExpenses
56000
CY2023Q1 us-gaap Other Expenses
OtherExpenses
288000
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
36567000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
46836000
CY2024Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-37863000
CY2023Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-90664000
CY2024Q1 stho Income Loss From Continuing Operations Before Income Loss From Equity Method Investments And Other Items
IncomeLossFromContinuingOperationsBeforeIncomeLossFromEquityMethodInvestmentsAndOtherItems
-48994000
CY2023Q1 stho Income Loss From Continuing Operations Before Income Loss From Equity Method Investments And Other Items
IncomeLossFromContinuingOperationsBeforeIncomeLossFromEquityMethodInvestmentsAndOtherItems
-120714000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
29974000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48994000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-90740000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-48996000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-90740000
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-15000
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-25000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-48981000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-90715000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.68
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.68
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.81
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.81
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13320000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13320000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13320000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13320000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-48996000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-90740000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-5933000
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-153000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-6922000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-153000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-989000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-49149000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-91729000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-15000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-25000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-49134000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-91704000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
433840000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-48996000
CY2024Q1 us-gaap Aoci Including Portion Attributable To Noncontrolling Interest Period Increase Decrease
AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease
-153000
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
7000
CY2024Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
27000
CY2024Q1 stho Minority Interest Increase Decrease From Other Changes
MinorityInterestIncreaseDecreaseFromOtherChanges
-3000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
384708000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
972269000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-90740000
CY2023Q1 us-gaap Aoci Including Portion Attributable To Noncontrolling Interest Period Increase Decrease
AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease
-989000
CY2023Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
3098000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1778000
CY2023Q1 us-gaap Stockholders Equity Note Spinoff Transaction
StockholdersEquityNoteSpinoffTransaction
-364781000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
520635000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-48996000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-90740000
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
17000
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1701000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1183000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1080000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1778000
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-244000
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-246000
CY2023Q1 stho Deferred Intereston Loans
DeferredInterestonLoans
4517000
CY2024Q1 stho Amortization Of Discounts Or Premiums Deferred Interest And Costs On Lending Investments
AmortizationOfDiscountsOrPremiumsDeferredInterestAndCostsOnLendingInvestments
-1934000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
29974000
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
19459000
CY2024Q1 us-gaap Straight Line Rent
StraightLineRent
-21000
CY2023Q1 us-gaap Straight Line Rent
StraightLineRent
-29000
CY2024Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-37863000
CY2023Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-90664000
CY2024Q1 stho Land Development Revenue In Excess Of Cost Of Sales
LandDevelopmentRevenueInExcessOfCostOfSales
4269000
CY2023Q1 stho Land Development Revenue In Excess Of Cost Of Sales
LandDevelopmentRevenueInExcessOfCostOfSales
-412000
CY2024Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-308000
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
162000
CY2024Q1 stho Increase Decrease In Accrued Interest And Operating Lease And Income Receivable
IncreaseDecreaseInAccruedInterestAndOperatingLeaseAndIncomeReceivable
-287000
CY2023Q1 stho Increase Decrease In Accrued Interest And Operating Lease And Income Receivable
IncreaseDecreaseInAccruedInterestAndOperatingLeaseAndIncomeReceivable
-59000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-187000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
283000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1905000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
828000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14230000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-554000
CY2024Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
770000
CY2023Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
2168000
CY2024Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
95000
CY2023Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
83000
CY2024Q1 stho Paymentfor Capital Expenditureson Landand Development Assets
PaymentforCapitalExpendituresonLandandDevelopmentAssets
6110000
CY2023Q1 stho Paymentfor Capital Expenditureson Landand Development Assets
PaymentforCapitalExpendituresonLandandDevelopmentAssets
2134000
CY2023Q1 stho Proceeds From Principal Repayments On Portfolio Of Assets
ProceedsFromPrincipalRepaymentsOnPortfolioOfAssets
24990000
CY2024Q1 us-gaap Proceeds From Sale Of Loans Receivable
ProceedsFromSaleOfLoansReceivable
0
CY2023Q1 us-gaap Proceeds From Sale Of Loans Receivable
ProceedsFromSaleOfLoansReceivable
37650000
CY2024Q1 stho Proceeds From Sale Of Land And Development Assets
ProceedsFromSaleOfLandAndDevelopmentAssets
16579000
CY2023Q1 stho Proceeds From Sale Of Land And Development Assets
ProceedsFromSaleOfLandAndDevelopmentAssets
9564000
CY2023Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
46488000
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-30000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2472000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9634000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
116779000
CY2023Q1 stho Proceeds Payments Of Financing Transactions With Istar
ProceedsPaymentsOfFinancingTransactionsWithIstar
-290077000
CY2023Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
253070000
CY2023Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
10000000
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1261000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-48268000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4596000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
67957000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60714000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7474000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56118000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75431000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45729000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70238000
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
10389000
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
5193000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56118000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75431000
CY2023Q1 stho Common Stock In Affiliate Received In Spinoff
CommonStockInAffiliateReceivedInSpinoff
13522651
CY2023Q1 stho Percentage Of Common Shares Of Beneficial Interest Distributed At Spinoff
PercentageOfCommonSharesOfBeneficialInterestDistributedAtSpinoff
1
CY2023Q1 stho Pro Rata Distribution Common Shares Issued For Outstanding Shares At Spinoff
ProRataDistributionCommonSharesIssuedForOutstandingSharesAtSpinoff
0.153
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q1 stho General And Administrative Expense Allocated
GeneralAndAdministrativeExpenseAllocated
14100000
CY2023Q1 stho Interest Expense Allocated
InterestExpenseAllocated
8000000.0
CY2023Q3 stho Debt Securities Interest Rate Stated Percentage
DebtSecuritiesInterestRateStatedPercentage
0.070
CY2024Q1 stho Tenant Expense Reimbursements
TenantExpenseReimbursements
400000
CY2023Q1 stho Tenant Expense Reimbursements
TenantExpenseReimbursements
400000
CY2023 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
359000
CY2023Q4 stho Debt Securities Available For Sale Face Value
DebtSecuritiesAvailableForSaleFaceValue
4220000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4220000
CY2023 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
359000
CY2023Q3 stho Number Of Securities Acquired
NumberOfSecuritiesAcquired
2
CY2023Q3 stho Debt Securities Available For Sale Acquired During Period
DebtSecuritiesAvailableForSaleAcquiredDuringPeriod
4200000
CY2024Q1 stho Other Lending Investments
OtherLendingInvestments
5196000
CY2023Q4 stho Other Lending Investments
OtherLendingInvestments
4579000
CY2024Q1 stho Notes Receivable And Other Lending Investments Before Allowance For Credit Losses
NotesReceivableAndOtherLendingInvestmentsBeforeAllowanceForCreditLosses
22755000
CY2023Q4 stho Notes Receivable And Other Lending Investments Before Allowance For Credit Losses
NotesReceivableAndOtherLendingInvestmentsBeforeAllowanceForCreditLosses
21395000
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
514000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
497000
CY2024Q1 stho Notes Receivable And Other Lending Investments Net Of Allowance For Credit Losses
NotesReceivableAndOtherLendingInvestmentsNetOfAllowanceForCreditLosses
22241000
CY2023Q4 stho Notes Receivable And Other Lending Investments Net Of Allowance For Credit Losses
NotesReceivableAndOtherLendingInvestmentsNetOfAllowanceForCreditLosses
20898000
CY2023Q4 stho Allowance For Credit Loss
AllowanceForCreditLoss
497000
CY2024Q1 stho Credit Loss Expense Reversal
CreditLossExpenseReversal
17000
CY2024Q1 stho Allowance For Credit Loss
AllowanceForCreditLoss
514000
CY2022Q4 stho Allowance For Credit Loss
AllowanceForCreditLoss
925000
CY2023Q1 stho Credit Loss Expense Reversal
CreditLossExpenseReversal
-467000
CY2023Q1 stho Allowance For Credit Loss
AllowanceForCreditLoss
458000
CY2024Q1 stho Financing Receivable And Unfunded Commitments Credit Loss Expense Reversal
FinancingReceivableAndUnfundedCommitmentsCreditLossExpenseReversal
17000
CY2023Q1 stho Financing Receivable And Unfunded Commitments Credit Loss Expense Reversal
FinancingReceivableAndUnfundedCommitmentsCreditLossExpenseReversal
1700000
CY2024Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
17559000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
16816000
CY2024Q1 stho Debt Securities Available For Sale Face Value
DebtSecuritiesAvailableForSaleFaceValue
4990000
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4990000
CY2024Q1 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
206000
CY2024Q1 stho Debt Securities Available For Sale Face Value
DebtSecuritiesAvailableForSaleFaceValue
4990000
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4990000
CY2024Q1 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
206000
CY2023Q4 stho Debt Securities Available For Sale Face Value
DebtSecuritiesAvailableForSaleFaceValue
4220000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4220000
CY2024Q1 stho Number Of Securities Acquired
NumberOfSecuritiesAcquired
1
CY2024Q1 stho Debt Securities Available For Sale Acquired During Period
DebtSecuritiesAvailableForSaleAcquiredDuringPeriod
800000
CY2024Q1 stho Debt Securities Interest Rate Stated Percentage
DebtSecuritiesInterestRateStatedPercentage
0.070
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
278567000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
316451000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
29974000
CY2024Q1 us-gaap Other Assets
OtherAssets
8058000
CY2023Q4 us-gaap Other Assets
OtherAssets
8882000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1267000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1380000
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10389000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10051000
CY2024Q1 us-gaap Other Receivables
OtherReceivables
2502000
CY2023Q4 us-gaap Other Receivables
OtherReceivables
1865000
CY2024Q1 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
92000
CY2023Q4 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
101000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
165000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
180000
CY2024Q1 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
22473000
CY2023Q4 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
22459000
CY2024Q1 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
200000
CY2023Q4 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
200000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
200000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
200000
CY2024Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P3Y7M6D
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
35754000
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
35010000
CY2024Q1 stho Accrued Liabilities Other Than Interest
AccruedLiabilitiesOtherThanInterest
5991000
CY2023Q4 stho Accrued Liabilities Other Than Interest
AccruedLiabilitiesOtherThanInterest
5914000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1428000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1538000
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
43173000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
42462000
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20900000
CY2024Q1 us-gaap Management Fee Payable
ManagementFeePayable
7600000
CY2024Q1 stho Other Real Estate Payables
OtherRealEstatePayables
5500000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20100000
CY2023Q4 us-gaap Management Fee Payable
ManagementFeePayable
7200000
CY2023Q4 stho Other Real Estate Payables
OtherRealEstatePayables
4900000
CY2024Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
500000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
364000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
486000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
486000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
162000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
0
CY2024Q1 stho Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
0
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1498000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
70000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1428000
CY2024Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.030
CY2024Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P3Y1M6D
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q1 stho Percentage Of Common Shares Of Beneficial Interest Distributed At Spinoff
PercentageOfCommonSharesOfBeneficialInterestDistributedAtSpinoff
1
CY2023Q1 stho Pro Rata Distribution Common Shares Issued For Outstanding Shares At Spinoff
ProRataDistributionCommonSharesIssuedForOutstandingSharesAtSpinoff
0.153
CY2024Q1 stho Number Of Classes Of Common Stock
NumberOfClassesOfCommonStock
1
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13319552
CY2024Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-48996000
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-90740000
CY2024Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-15000
CY2023Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-25000
CY2024Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-48981000
CY2023Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-90715000
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-48981000
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-48981000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-90715000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-90715000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13320000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13320000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13320000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13320000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.68
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.68
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.81
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.81
CY2023Q1 stho Pro Rata Distribution Common Shares Issued For Outstanding Shares At Spinoff
ProRataDistributionCommonSharesIssuedForOutstandingSharesAtSpinoff
0.153
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001953366-24-000014-index-headers.html Edgar Link pending
0001953366-24-000014-index.html Edgar Link pending
0001953366-24-000014.txt Edgar Link pending
0001953366-24-000014-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stho-20240331.xsd Edgar Link pending
stho-20240331x10q.htm Edgar Link pending
stho-20240331xex31d0.htm Edgar Link pending
stho-20240331xex32d0.htm Edgar Link pending
stho-20240331_def.xml Edgar Link unprocessable
stho-20240331_pre.xml Edgar Link unprocessable
stho-20240331x10q_htm.xml Edgar Link completed
stho-20240331_cal.xml Edgar Link unprocessable
stho-20240331_lab.xml Edgar Link unprocessable